Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Triple A syndrome is a very rare multisystem disease characterized by adrenal insufficiency with isolated glucocorticoid deficiency, achalasia, alacrima, autonomic dysfunction and neurodegeneration.
Features include always present findings: Achalasia and Alacrima; and very common findings: Adrenal insufficiency. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Ataxia, Problems with involuntary body functions (abnormal autonomic nervous system physiology), Motor axonal neuropathy |
Skin | 2 | Hyperpigmentation of the skin, Palmoplantar hyperkeratosis |
Muscles | 2 | Muscle weakness, Damage to the optic nerve (optic atrophy) |
Hormones | 2 | Decreased circulating cortisol level, Adrenal insufficiency |
Growth and development | 1 | Short stature |
Head and neck | 1 | Microcephaly |
Digestive system | 1 | Achalasia |
Lab test results | 1 | Decreased circulating cortisol level |
Eyes | 1 | Damage to the optic nerve (optic atrophy) |
AAAS encodes aladin WD repeat nucleoporin (546 aa). Plays a role in the normal development of the peripheral and central nervous system.
Triple-A syndrome is associated with mutations in the AAAS gene on chromosome 12.
The AAAS protein participates in AFG3L2 (m-AAA protease) degrades SMDT1 that is not assembled in MCU and PGRMC2:Hemes translocate to the nucleus pathways.
AAAS is classified as a druggable target (Transporter category) with score 0.0.
57 pathogenic variants reported in AAAS in ClinVar, including hotspot variants 264994 (2-star review) and 264993.
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
264994 | Pathogenic | 2 stars | Yes |
264993 | Pathogenic/Likely pathogenic | — | Yes |
NP_001166937.1:p.Ser230Pro | Pathogenic/Likely pathogenic | 2 stars | Yes |
NP_001166937.1:p.Gln15Lys | Pathogenic | 2 stars | Yes |
NP_001166937.1:p.Arg445Ter | Pathogenic | 2 stars | Yes |
Genetic testing for AAAS is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for triple-A syndrome has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 1 very common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for triple-A syndrome.
21 publications have been identified in PubMed for triple-A syndrome. Research spans Case Report / Case Series (57%), Epidemiology / Natural History (14%), and Review / Meta-Analysis (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 57% |
Disease patterns and progression | 3 | 14% |
Research summaries | 2 | 10% |
Laboratory research | 2 | 10% |
Testing and diagnosis research | 1 | 5% |
Clinical study results | 1 | 5% |
Juścińska E (2026). [PMID: 41498959](https://pubmed.ncbi.nlm.nih.gov/41498959/). *Neurogenetics*. [Epidemiology / Natural History]
Siokas V (2026). [PMID: 42091675](https://pubmed.ncbi.nlm.nih.gov/42091675/). *Neurogenetics*. [Case Report / Case Series]
Sheikh MM (2026). [PMID: 32809536](https://pubmed.ncbi.nlm.nih.gov/32809536/). *Unknown Journal*. [Review / Meta-Analysis]
Faria N (2026). [PMID: 42055466](https://pubmed.ncbi.nlm.nih.gov/42055466/). *Endocrinol Diabetes Metab Case Rep*. [Case Report / Case Series]
Salame H (2026). [PMID: 41560097](https://pubmed.ncbi.nlm.nih.gov/41560097/). *Medicine*. [Case Report / Case Series]
Kushwaha DS (2025). [PMID: 41426934](https://pubmed.ncbi.nlm.nih.gov/41426934/). *Cureus*. [Case Report / Case Series]
Boz PB (2025). [PMID: 40476452](https://pubmed.ncbi.nlm.nih.gov/40476452/). *Ideggyogyaszati szemle*. [Case Report / Case Series]
Bozkına AÇ (2025). [PMID: 41020932](https://pubmed.ncbi.nlm.nih.gov/41020932/). *Revista espanola de enfermedades digestivas*. [Case Report / Case Series]
Singhal N (2025). [PMID: 39926264](https://pubmed.ncbi.nlm.nih.gov/39926264/). *Radiology case reports*. [Case Report / Case Series]
Bozkına AÇ (2025). [PMID: 41128112](https://pubmed.ncbi.nlm.nih.gov/41128112/). *Revista espanola de enfermedades digestivas*. [Clinical Trial Publication]
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 6:33 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center